The data on CHF were obtained from six RCTs [28,30–34] analyzing a total of 4,779 and 4,879 HER2-positive EBC women in the trastuzumab-chemotherapy and the chemotherapy alone groups, respectively. This evidence concerns the gene ERBB2 and congestive heart failure.